Shalby moves up as its Krishna unit gets approval for Kidney Transplant for 5 years
Shalby is currently trading at Rs. 155.00, up by 1.45 points or 0.94% from its previous closing of Rs. 153.55 on the BSE.
The scrip opened at Rs. 153.55 and has touched a high and low of Rs. 155.85 and Rs. 148.05 respectively. So far 9787 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 274.50 on 22-Sep-2025 and a 52 week low of Rs. 125.70 on 30-Mar-2026.
Last one week high and low of the scrip stood at Rs. 158.20 and Rs. 137.30 respectively. The current market cap of the company is Rs. 1659.57 crore.
The promoters holding in the company stood at 74.33%, while Institutions and Non-Institutions held 4.67% and 21.01% respectively.
Shalby’s Krishna unit in Ahmedabad, Gujarat, -- Shalby Hospitals has received the approval for Kidney Transplant for a period of 5 years with effect from April 9, 2026. This approval to the company’s facility will enables patients in the surrounding community to access advanced, life-saving transplant services locally, reducing the need for long-distance travel and associated costs. It enhances continuity of care by offering comprehensive pre-and post-transplant management under one roof.
